Hailiang Xin
Overview
Explore the profile of Hailiang Xin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Han J, Xia T, Jiang Y, Fan W, Wang N, Zhang Y, et al.
Cell Biochem Biophys
. 2024 Jul;
82(4):3425-3435.
PMID: 39033477
Xanthohumol (XAN) is an isoprenyl flavonoid from Humulus lupulus L. known for beer brewing, and an osteoprotective agent due to its active improvement in bone loss of osteoporosis. This study...
2.
Xu W, Jiang T, Ding L, Jiang Y, Zhang L, Xia T, et al.
J Nat Med
. 2024 Mar;
78(3):488-504.
PMID: 38530577
Osteoporosis (OP) is closely related to iron overload. Bajitianwan (BJTW) is a traditional Chinese medicine formulation used for treating senile diseases such as dementia and osteoporosis. Modern pharmacological researches have...
3.
Jiang T, Xia T, Qiao F, Wang N, Jiang Y, Xin H
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003376
Bones serve mechanical and defensive functions, as well as regulating the balance of calcium ions and housing bone marrow.. The qualities of bones do not remain constant. Instead, they fluctuate...
4.
Li K, Jiang Y, Wang N, Lai L, Xu S, Xia T, et al.
Am J Chin Med
. 2023 Oct;
51(8):1957-1981.
PMID: 37884447
The gut microbiome (GM) has become a crucial factor that can affect the progression of osteoporosis. A number of studies have demonstrated the impact of Traditional Chinese Medicine (TCM) on...
5.
Li K, Xia T, Jiang Y, Wang N, Lai L, Xu S, et al.
J Ethnopharmacol
. 2023 Sep;
319(Pt 2):117211.
PMID: 37739100
Ethnopharmacological Relevance: Portulaca oleracea L. (PO), popularly known as purslane, has been documented in ethnopharmacology in various countries and regions. Traditional application records indicated that PO might be used extensively...
6.
Ling Y, Wen X, Tang J, Tao Z, Sun L, Xin H, et al.
CNS Neurosci Ther
. 2023 Sep;
30(3):e14421.
PMID: 37679900
Aims: The electroencephalography (EEG) microstates are indicative of fundamental information processing mechanisms, which are severely damaged in patients with prolonged disorders of consciousness (pDoC). We aimed to improve the topographic...
7.
Xia T, Zhang J, Guo Y, Jiang Y, Qiao F, Li K, et al.
Molecules
. 2023 Jan;
28(2).
PMID: 36677642
As aging progresses, -amyloid (A) deposition and the resulting oxidative damage are key causes of aging diseases such as senior osteoporosis (SOP). L. (hops) is an important medicinal plant widely...
8.
Xu W, Jiang Y, Wang N, Bai H, Xu S, Xia T, et al.
Front Pharmacol
. 2022 Jun;
13:842101.
PMID: 35721142
Alzheimer's disease (AD) and osteoporosis (OP) are progressive degenerative diseases caused by multiple factors, placing a huge burden on the world. Much evidence indicates that OP is a common complication...
9.
Xia T, Liu X, Wang N, Jiang Y, Bai H, Xu W, et al.
J Pharm Pharmacol
. 2022 Mar;
74(7):1017-1026.
PMID: 35353176
Objective: Xanthohumol (XAN), a natural isoflavone from Humulus lupulus L., possesses biological activities on relieving oxidative stress and osteoporosis (OP). This study aimed to evaluate the antioxidative and osteoprotective effect...
10.
Sun X, Xia T, Zhang S, Zhang J, Xu L, Han T, et al.
J Bone Miner Metab
. 2022 Feb;
40(3):375-388.
PMID: 35106609
Introduction: Osteoporosis is closely related to iron metabolism. This study aimed to investigate whether hops extract (HLE) and its active component xanthohumol (XAN) could ameliorate bone loss caused by iron...